ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814RE
FDA Device Recall #Z-1491-2023 — Class I — March 24, 2023
Recall Summary
| Recall Number | Z-1491-2023 |
| Classification | Class I — Serious risk |
| Date Initiated | March 24, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Cordis US Corp |
| Location | Miami Lakes, FL |
| Product Type | Devices |
| Quantity | 1087 units |
Product Description
ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814RE
Reason for Recall
There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.
Distribution Pattern
Worldwide distribution.
Lot / Code Information
UDI/DI 20705032054772; Lot Numbers: 35264217, 35264226, 35265330, 35265344, 35265381, 35265641, 35265652, 35265655, 35264205, 35264210, 35264214, 35265340, 35265341, 35265394, 35265643
Other Recalls from Cordis US Corp
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1511-2025 | Class II | Cordis, REF: C09060ML, Smart Control Vascular S... | Mar 4, 2025 |
| Z-1510-2025 | Class II | Cordis, REF C10040ML, Smart Control Vascular St... | Mar 4, 2025 |
| Z-1330-2025 | Class II | Vista Brite Tip, Judkins Right 4, REF SM7504, J... | Feb 7, 2025 |
| Z-0675-2024 | Class II | MYNXGRIP 6F/7F, REF MX6721, Vascular Closure De... | Nov 28, 2023 |
| Z-0674-2024 | Class II | MYNXGRIP 5F, REF MX5021, Vascular Closure Devic... | Nov 28, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.